BRAF V600E MUTATION POSITIVE
Clinical trials for BRAF V600E MUTATION POSITIVE explained in plain language.
Never miss a new study
Get alerted when new BRAF V600E MUTATION POSITIVE trials appear
Sign up with your email to follow new studies for BRAF V600E MUTATION POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise in shrinking tough colon tumors before surgery
Disease control Recruiting nowThis study is testing whether giving two drugs (encorafenib and cetuximab) before surgery can shrink tumors in people with a specific genetic mutation (BRAF V600E) in colon or upper rectal cancer. About 30 participants will receive the drugs for 6 weeks before their planned surge…
Matched conditions: BRAF V600E MUTATION POSITIVE
Phase: PHASE2 • Sponsor: Federation Francophone de Cancerologie Digestive • Aim: Disease control
Last updated Jun 26, 2026 12:58 UTC
-
Researchers launch study to track Real-World outcomes in BRAF-Mutated colorectal cancer
Knowledge-focused Recruiting nowThis study is collecting medical information and blood samples from 400 people with metastatic colorectal cancer that has a specific genetic change called BRAFV600E. The goal is to learn more about how this cancer is treated in everyday practice and what outcomes patients experie…
Matched conditions: BRAF V600E MUTATION POSITIVE
Phase: NA • Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC